Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00665431 · ClinicalTrials.gov registry record · Phase 3
Efficacy Study of PN400 (VIMOVO) Twice Daily and Celebrex Once Daily in Patients With Osteoarthritis
A Phase 3 study, sponsored by POZEN.
- Completed
- Registry status
- Phase 3
- Development phase
- 610
- Enrollment target
NCT00665431 is a Phase 3 study that has completed, run by POZEN. The registered enrollment target is 610 participants.
The verdict
NCT00665431, a Phase 3 study, has completed, sponsored by POZEN.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 610 participants
- Enrollment target
Study Summary
We will evaluate the efficacy of PN 400 and an active comparator in patients that have Osteoarthritis of the knee.
Interventions
- OTHER Placebo
- DRUG PN 400 (VIMOVO)
- DRUG celebrex
- DRUG Rescue Antacid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 610 participants |
| Start Date | 2008-04 |
| Est. Completion | 2009-01 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00665431
The ClinicalTrials.gov registry entry for NCT00665431 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 610 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is POZEN, which has 24 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Placebo is the first listed.
NCT00665431 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00665431 about?
NCT00665431 is a clinical study titled "Efficacy Study of PN400 (VIMOVO) Twice Daily and Celebrex Once Daily in Patients With Osteoarthritis". We will evaluate the efficacy of PN 400 and an active comparator in patients that have Osteoarthritis of the knee.
What is the current status of trial NCT00665431?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 610 participants. The study started on 2008-04. Estimated completion is 2009-01.
What interventions are being tested in trial NCT00665431?
The interventions under investigation include: Placebo (OTHER), PN 400 (VIMOVO) (DRUG), celebrex (DRUG), Rescue Antacid (DRUG).
Who is sponsoring clinical trial NCT00665431?
This trial is sponsored by POZEN, which has 24 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.